Front Page-Rx

State legislatures across the country continue efforts to address the opaque business practices of pharmacy benefit managers (PBMs) to protect consumers and lower prescription drug prices. Montana is taking a new approach by leveraging its insurance department’s regulatory authority over insurance carriers by proposing a bill that tasks insurers with responsibility for overseeing that PBMs […]

Read More
  • State Health Policy Blog

    Annual Federal Insurance Rule Includes Proposals to Address Prescription Drug Cost

    The Trump Administration’s effort to address drug prices surfaced unexpectedly in the Department of Health and Human Services (HHS)’s recently issued proposed annual rule that regulates state health insurance markets, including coverage sold through the Affordable Care Act (ACA) marketplaces. The proposal encourages the use of generic drugs over brand-name drugs by both health plans and enrollees […]

    Read More
  • State Health Policy Blog
    New Tools Help States Document Rx Costs and Identify Potential Savings

    New Tools Help States Document Rx Costs and Identify Potential Savings

    Just how much are states spending on prescription drugs? And, which drugs account for their greatest expense? As state policymakers grapple with solutions to the problem of rising drug costs, officials are performing research to  provide critical evidence and tools needed to inform policy. Two recent state efforts to document their prescription drug costs may […]

    Read More
  • State Health Policy Blog
    As State Legislatures Convene, Lawmakers Quickly Submit Bills to Curb Prescription Prices

    As State Legislatures Convene, Lawmakers Quickly Submit Bills to Curb Prescription Prices

    One week into the 2019 legislative season, lawmakers from 11 states have already submitted 30 bills to address the rising cost of prescription drugs. The bills submitted to date seek to implement wholesale drug importation programs, increase pharmaceutical pricing transparency, and regulate pharmacy benefit managers (PBMs), along with other drug cost containment initiatives. Last year, […]

    Read More
  • Maps
    State Legislative Action to Lower Pharmaceutical Costs

    State Legislative Action to Lower Pharmaceutical Costs

    Updated Sept. 26, 2019* Find the status of state legislation to address prescription drug costs below. Use the category button to search by type of legislation and roll over a state to view its pending drug legislation. Download or view a chart listing 2019 legislation by state. View state action in 2018, 2017, and 2015-2016. Email information about new bills or legislative action to Sarah Lanford. This map […]

    Read More
    January 7, 2019 | Filed under: Featured, Featured-Rx, Front Page-Rx, Maps, Rx Featured New

  • State Health Policy Blog
    States Take Administrative Actions to Curb Medicaid Drug Costs

    States Take Administrative Actions to Curb Medicaid Drug Costs

    During the 2018 legislative session, 28 states passed 45 laws to curb the rising cost of prescription drugs. In addition to legislative solutions, states are taking administrative action to better manage state spending on Medicaid pharmacy benefits. Ohio, West Virginia, and Vermont offer examples of states taking innovative administrative approaches to rein in drug costs. […]

    Read More
  • Comparison of State Pharmacy Benefit Managers Laws

    Comparison of State Pharmacy Benefit Managers Laws

    In 2018, 21 states passed 32 bills to shed light on the opaque business practices of pharmacy benefit managers (PBMs). States took varied approaches to curb prescription drug costs by regulating PBMs. The chart below details the PBM practices each state tackled, and how their approaches compare with NASHP’s PBM model legislation.   Footnotes 1. Bills […]

    Read More
    October 4, 2018 | Filed under: Front Page-Rx, Importation, Pharmacy Benefit Manager, Rx

  • NASHP Issues RFP for Partner to Help States Develop a Drug Cost Transparency Database

    NASHP Issues RFP for Partner to Help States Develop a Drug Cost Transparency Database

    NASHP’s Center for State Rx Drug Pricing seeks a partner to provide technical and strategic expertise to help a workgroup of state officials from California, Nevada, Oregon, Connecticut, and Vermont implement their drug cost transparency laws and help Maine and New Hampshire develop transparency programs as mandated by recent legislation. This work will help all […]

    Read More
    September 18, 2018 | Filed under: Drug Pricing, Featured-Rx, Front Page, Front Page-Rx, Transparency

  • State Health Policy Blog
    As States Take the Lead to Address Drug Costs, Federal Action Follows

    As States Take the Lead to Address Drug Costs, Federal Action Follows

    *Update: On Oct. 10, 2018, President Trump signed two bills designed to increase prescription drug price transparency by prohibiting gag clauses, which prevent pharmacists from disclosing lower-cost drug options to consumers. One bill prohibits gag clauses under Medicare Part D starting in 2020 and the other affects private insurance markets and goes into effect immediately. […]

    Read More
  • State Health Policy Blog
    New NASHP Model Legislation Helps States Bring Transparency to Pharmacy Benefit Managers

    New NASHP Model Legislation Helps States Bring Transparency to Pharmacy Benefit Managers

    The National Academy for State Health Policy (NASHP) has released model legislation to help states shed light on the opaque business practices of pharmacy benefit managers (PBMs). States can use the model bill to require the licensing of PBMs, ban gag clauses that prevent pharmacists from sharing lower-price drug options with consumers, and require more […]

    Read More